US OptionsDetailed Quotes
REGN250110C770000
- 0.90
- 0.000.00%
15min DelayClose Jan 10 16:00 ET
0.00High0.00Low
0.00Open0.90Pre Close0 Volume12 Open Interest770.00Strike Price0.00Turnover2577.66%IV14.07%PremiumJan 10, 2025Expiry Date0.00Intrinsic Value100Multiplier-14DDays to Expiry0.90Extrinsic Value100Contract SizeAmericanOptions Type0.0525Delta0.0026Gamma750.88Leverage Ratio-1088.7141Theta0.0000Rho39.41Eff Leverage0.0017Vega
Regeneron Pharmaceuticals Stock Discussion
Sign in to post a comment
$Esperion Therapeutics (ESPR.US)$ Jan 23, 2025 Three analysts are bullish on Esperion Therapeutics with price targets on this $2 stock ranging from $7 to $16 a share.
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...
5
3
2
$Regeneron Pharmaceuticals (REGN.US)$ Wow, that was a nice dip buying. I didn’t follow their events closely. I bought back somewhat early on Jan 10.
$Regeneron Pharmaceuticals (REGN.US)$ It’s doing this kind of thing. Kind of scary. Nobody wants it for above 700.
$Regeneron Pharmaceuticals (REGN.US)$ This is in NDX and could benefit from the weakness of mega-cap tech stocks in the index.
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
I also think this is a great biopharmaceutical research and development company, I don't understand why it has been falling all the time.$Regeneron Pharmaceuticals (REGN.US)$Nice. It’s quiet here and just broke the steep down trend.
$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...
11
2
4
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
14
1
4
🔥 We go over 5 stocks that look undervalued, i show you the numbers for yourself, i own 1 of the stocks on the list, but i try to go over stocks you’ve probably never heard of before! LMK ur thoughts :)
$Hershey (HSY.US)$ $Celsius Holdings (CELH.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $Yelp Inc (YELP.US)$ $Innovative Industrial Properties Inc (IIPR.US)$
$Hershey (HSY.US)$ $Celsius Holdings (CELH.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $Yelp Inc (YELP.US)$ $Innovative Industrial Properties Inc (IIPR.US)$
From YouTube
1
Utilities: $NextEra Energy (NEE.US)$ $Duke Energy (DUK.US)$ $Southern (SO.US)$ $Consolidated Edison (ED.US)$ $Public Service Enterprise Group (PEG.US)$
Crypto: $Coinbase (COIN.US)$ $GEMINI GROUP GLOBAL CORP (GMNI.US)$ $Riot Platforms (RIOT.US)$
Financials: $JPMorgan (JPM.US)$ $Morgan Stanley (MS.US)$ $Wells Fargo & Co (WFC.US)$
Traditional Energy: $Exxon Mobil (XOM.US)$ $Chevron (CVX.US)$ $ConocoPhillips (COP.US)$
Biotechnology: $Amgen (AMGN.US)$ $Gilead Sciences (GILD.US)$ $ROCHE HOLDING AG (RHHBY.US)$ $Biogen (BIIB.US)$ $Regeneron Pharmaceuticals (REGN.US)$
...
Crypto: $Coinbase (COIN.US)$ $GEMINI GROUP GLOBAL CORP (GMNI.US)$ $Riot Platforms (RIOT.US)$
Financials: $JPMorgan (JPM.US)$ $Morgan Stanley (MS.US)$ $Wells Fargo & Co (WFC.US)$
Traditional Energy: $Exxon Mobil (XOM.US)$ $Chevron (CVX.US)$ $ConocoPhillips (COP.US)$
Biotechnology: $Amgen (AMGN.US)$ $Gilead Sciences (GILD.US)$ $ROCHE HOLDING AG (RHHBY.US)$ $Biogen (BIIB.US)$ $Regeneron Pharmaceuticals (REGN.US)$
...
7
5
Esperion $Esperion Therapeutics (ESPR.US)$ We reiterate Strong Buy rating. Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 million Americans take statin drugs, we see continued prescription growth & expect over 5...
+20
14
No comment yet
Growth Investor27 : I own a lot & will buy more
DazzlerAus : agree but nothing seems to help
Youngman : I keep hearing nothing but good things about the stock while it goes down lol